The Impact of Disease Modification on the Cost-Effectiveness of Pegloticase for the Treatment of Severe Debilitating Chronic Tophaceous Gout In Adult Patients
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2617
https://www.valueinhealthjournal.com/article/S1098-3015(14)04566-5/fulltext
Title :
The Impact of Disease Modification on the Cost-Effectiveness of Pegloticase for the Treatment of Severe Debilitating Chronic Tophaceous Gout In Adult Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04566-5&doi=10.1016/j.jval.2014.08.2617
First page :
A381
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
324